This product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the Food and Drug Administration.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your healthcare provider before using herbs, especially if you are pregnant, nursing, taking medications, or have a medical condition.
This herb is NOT recommended during pregnancy due to potential risks to the developing fetus.
This herb is NOT recommended while breastfeeding as effects on infants are unknown.
Consult your healthcare provider before use.
4 Known Drug Interactions — Some May Be Serious
1 Severe3 Moderate
This herb may interact with medications you are taking. Review the interactions table below and consult your healthcare provider before use.
What is a herb–drug interaction?
A herb–drug interaction happens when a plant or supplement changes how a medication works in your body — making it stronger, weaker, or more likely to cause harm. Herbs contain active compounds that can speed up or slow down the enzymes and transporters your body uses to process drugs.
Why it matters
•St. John's Wort can make birth control, antidepressants, and blood thinners less effective.
•Garlic can increase bleeding risk with warfarin and other blood thinners (also ginkgo, ginger, and turmeric).
•Kava can amplify sedation when taken with anxiety or sleep medications (also valerian).
The risk is highest for older adults, anyone taking several medications, and people with chronic conditions.
Always tell your doctor and pharmacist about every herb and supplement you take — and check below before combining.
Known Drug Interactions (4)
1 Severe3 Moderate
Drug
Severity
Description
Losartan
Moderate
Berberine may increase losartan levels and its active metabolite, potentially enhancing blood pressure effects.
Cyclosporine
Severe
Berberine significantly increases cyclosporine blood levels (by nearly 100% in one study), increasing risk of toxicity.
Dextromethorphan
Moderate
Berberine may increase dextromethorphan blood levels by inhibiting its metabolism.
Metformin
Moderate
Berberine has similar blood sugar-lowering mechanisms to metformin. Combining them may cause excessive blood sugar reduction (hypoglycemia).
This list reflects a curated subset of documented interactions and is not exhaustive. The absence of a drug here is not proof that it is safe to combine. Always confirm with a pharmacist or healthcare provider.
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 29 PubMed articles · model: gemma4:31b
Summary
Berberine is an isoquinoline alkaloid found in Berberis vulgaris and other plants, demonstrating wide-ranging pharmacological activities including antidiabetic, lipid-lowering, and antimicrobial effects [PMID:30637820, PMID:32335802].
Background
Berberine is a quaternary ammonium salt from the protoberberine group of isoquinoline alkaloids [PMID:27671811]. It is found in various plants, including Berberis vulgaris (barberry), Berberis aquifolium (Oregon grape), Berberis aristata (tree turmeric), Coptis chinensis (Chinese goldthread), and Hydrastis canadensis (goldenseal) [PMID:27671811, PMID:33242239].
Traditional uses
In traditional Chinese medicine, it has been used for many years to address conditions such as diarrhea and dysentery [PMID:38522318, PMID:11607041]. Barberry has various medicinal applications in the folk medicine of Iran [PMID:30637820].
Active compounds
The primary active compound is berberine, an isoquinoline alkaloid present in the roots, rhizomes, stem, and bark of B. vulgaris [PMID:30637820, PMID:33242239]. Other compounds in barberry species include anthocyanins, flavonoids, phenolic compounds, vitamins, minerals, and berbamine [PMID:31077383, PMID:24600191].
Mechanism of action
Berberine exerts effects through antioxidant, anti-inflammatory, and antimicrobial activities [PMID:35889396]. It may regulate the gastrointestinal microbiota to improve insulin resistance and lipid-lowering [PMID:33680978, PMID:41243097]. Molecular mechanisms include inducing apoptosis, activating autophagy, and inhibiting cancer cell proliferation [PMID:35889396, PMID:32735398]. In the nervous system, it may act via the Pl3K/Akt/Bcl-2, Nrf2/HO-1, and MAPK signaling pathways [PMID:29732634]. Cardiovascular effects are attributed to the blockade of K+ channels and stimulation of the Na+-Ca(2+) exchanger [PMID:11607041].
Lipid-lowering actions have been clearly demonstrated in numerous randomized clinical trials [PMID:30637820, PMID:27671811].
Evidence CCancer
Inhibits proliferation of various cancer cells and improves the efficacy and safety of chemoradiotherapies [PMID:32335802].
Evidence CCardiovascular Disease
Preliminary evidence suggests a reduction in endothelial inflammation and improvement in vascular health [PMID:27671811].
Evidence CGastrointestinal Disorders
Can inhibit toxins and bacteria, including Helicobacter pylori, and protect the intestinal epithelial barrier [PMID:32335802].
Safety & adverse effects
Berberine generally has very low toxicity in usual doses and reveals clinical benefits without major side effects [PMID:30637820, PMID:33680978]. However, some reports indicate it could induce gastrointestinal upset and ulceration, with toxicity depending on the route and duration of administration [PMID:28656087]. It has not been linked to serum aminotransferase elevations or clinically apparent liver injury [PMID:33242239].
Drug interactions
Concomitant administration of berberine with other drugs such as metformin, cyclosporine A, and digoxin may result in important interactions [PMID:36221815].
Evidence summary
The evidence for berberine's effects on glycemic control and lipid metabolism is strong, supported by systematic reviews and RCTs. Evidence for anticancer, neuroprotective, and cardiovascular effects is primarily based on reviews and animal/in vitro models.
PubMed sources
1.PMID: 30637820 (2019) — Berberine and barberry (Berberis vulgaris): A clinical review. · Phytotherapy research : PTR
2.PMID: 32335802 (2020) — Biological properties and clinical applications of berberine. · Frontiers of medicine
3.PMID: 28290706 (2017) — The metabolism of berberine and its contribution to the pharmacological effects. · Drug metabolism reviews
4.PMID: 27671811 (2016) — Berberine and Its Role in Chronic Disease. · Advances in experimental medicine and biology
5.PMID: 33680978 (2020) — Effects of Berberine on the Gastrointestinal Microbiota. · Frontiers in cellular and infection microbiology
Government sources
No direct government monograph is available for this herb. The content below is AI-generated and has not been verified against an authoritative government source. Use the search links to check official sources before relying on this information.
6.PMID: 35889396 (2022) — Anticancer Effects and Mechanisms of Berberine from Medicinal Herbs: An Update Review. · Molecules (Basel, Switzerland)
7.PMID: 38522318 (2024) — Inhibition of inflammation by berberine: Molecular mechanism and network pharmacology analysis. · Phytomedicine : international journal of phytotherapy and phytopharmacology
8.PMID: 33242239 (2012) — Berberine. · Alternative medicine review : a journal of clinical therapeutic
9.PMID: 25498346 (2015) — Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension. · Journal of ethnopharmacology
10.PMID: 27528198 (2016) — Berberis Vulgaris and Berberine: An Update Review. · Phytotherapy research : PTR
11.PMID: 28656087 (2017) — Toxicology effects of Berberis vulgaris (barberry) and its active constituent, berberine: a review. · Iranian journal of basic medical sciences
12.PMID: 39944624 (2025) — Advance in identified targets of berberine. · Frontiers in pharmacology
13.PMID: 29732634 (2018) — Berberine: Pathways to protect neurons. · Phytotherapy research : PTR
14.PMID: 11607041 (2001) — Cardiovascular actions of berberine. · Cardiovascular drug reviews
15.PMID: 31827685 (2019) — Anti-Inflammatory and Immunomodulatory Effects of Barberry (Berberis vulgaris) and Its Main Compounds. · Oxidative medicine and cellular longevity
16.PMID: 36221815 (2022) — Pharmacokinetic of berberine, the main constituent of Berberis vulgaris L.: A comprehensive review. · Phytotherapy research : PTR
17.PMID: 41243097 (2025) — Berberine ameliorates high-fat diet-induced metabolic disorders through promoting gut Akkermansia and modulating bile acid metabolism. · Chinese medicine
18.PMID: 31077383 (2019) — Investigating functional properties of barberry species: an overview. · Journal of the science of food and agriculture
19.PMID: 32735398 (2020) — Berberine: A novel therapeutic strategy for cancer. · IUBMB life
20.PMID: 28656085 (2017) — Berberis vulgaris for cardiovascular disorders: a scoping literature review. · Iranian journal of basic medical sciences
21.PMID: 24600191 (2014) — Phytochemistry and pharmacology of berberis species. · Pharmacognosy reviews
22.PMID: 35668943 (2022) — Berberine: A Promising Treatment for Neurodegenerative Diseases. · Frontiers in pharmacology
23.PMID: 36186093 (2022) — Neuroprotective Effect of Root Extracts of Berberis Vulgaris (Barberry) on Oxidative Stress on SH-SY5Y Cells. · Journal of pharmacopuncture
24.PMID: 33340158 (2021) — A review on pain-relieving activity of berberine. · Phytotherapy research : PTR
25.PMID: 27757035 (2016) — Role of berberine in Alzheimer's disease. · Neuropsychiatric disease and treatment
26.PMID: 31902359 (2020) — New Development of Novel Berberine Derivatives against Bacteria. · Mini reviews in medicinal chemistry
27.PMID: 32507431 (2020) — The effect of barberry (Berberis vulgaris L.) on glycemic indices: A systematic review and meta-analysis of randomized controlled trials. · Complementary therapies in medicine
28.PMID: 32564751 (2020) — Berberine Administration in Treatment of Colitis: A Review. · Current drug targets
29.PMID: 40319817 (2025) — Berberine alleviates tendinopathy by suppressing the cGAS-STING pathway and Relieving ferroptosis. · Biochemical and biophysical research communications